Show simple item record

Use of effective contraception following provision of the progestogen-only pill for women presenting to community pharmacies for emergency contraception (Bridge-It) : a pragmatic cluster-randomised crossover trial

dc.contributor.authorCameron, Sharon T
dc.contributor.authorGlasier, Anna
dc.contributor.authorMcDaid, Lisa
dc.contributor.authorRadley, Andrew
dc.contributor.authorBaraitser, Paula
dc.contributor.authorStephenson, Judith M
dc.contributor.authorGilson, Richard
dc.contributor.authorBattison, Claire G.
dc.contributor.authorCowle, Kathleen
dc.contributor.authorForrest, Mark
dc.contributor.authorGoulao, Beatriz
dc.contributor.authorJohnstone, Anne
dc.contributor.authorMorelli, Alessandra
dc.contributor.authorPatterson, Susan
dc.contributor.authorMcDonald, Alison
dc.contributor.authorVadiveloo, Thenmalar
dc.contributor.authorNorrie, John
dc.date.accessioned2020-11-23T15:37:01Z
dc.date.available2020-11-23T15:37:01Z
dc.date.issued2020-11-14
dc.identifier180240037
dc.identifier6413ea62-9c09-45c9-85fc-54dd919cdb04
dc.identifier85096153496
dc.identifier33189179
dc.identifier000588778800030
dc.identifier.citationCameron , S T , Glasier , A , McDaid , L , Radley , A , Baraitser , P , Stephenson , J M , Gilson , R , Battison , C G , Cowle , K , Forrest , M , Goulao , B , Johnstone , A , Morelli , A , Patterson , S , McDonald , A , Vadiveloo , T & Norrie , J 2020 , ' Use of effective contraception following provision of the progestogen-only pill for women presenting to community pharmacies for emergency contraception (Bridge-It) : a pragmatic cluster-randomised crossover trial ' , The Lancet , vol. 396 , no. 10262 , pp. 1585-1594 . https://doi.org/10.1016/S0140-6736(20)31785-2en
dc.identifier.issn0140-6736
dc.identifier.urihttps://hdl.handle.net/2164/15399
dc.descriptionAcknowledgments: We thank the participants of this study, community pharmacists who recruited women for the study, and health-care professionals at the sexual and reproductive health service clinics who assisted with the study implementation. We thank Deirde Sally, Nicola Stewart, and Maria Nunez for the support with study implementation at the local site in London and Kristina Saunders for support with the process evaluation. We also thank Sarah Cameron and Lorna Aucott (senior statistician, the Centre for Healthcare Randomised Trials) for support and Katherine Lewis, Laura Flett, and Judith Parker for trial management support. List of study pharmacies in Edinburgh: Newington Pharmacy, Boots Princes Street, Boots Shandwick Place, Boots Earl Grey Street, Boots Gyle, Boots St Patrick Street, Boots Multrees Walk, Boots Ocean Terminal, Boots Edinburgh Fort Retail Park, Boots Cameron Toll, Boots Craigleith, and Bristo Square Pharmacy. List of study pharmacies in London: Peace Pharmacy, Westbury Chemist, Baba Chemist, Lings Chemist, Streatham Day Lewis, Morrisons—Aylesham Centre, Evergreen Pharmacy, Greenlight Pharmacy, Sandylight Pharmacy, Greenfields, JP Pharmacy, Boots Goodge Street, Boots Tottenham Court Road, and Boots Holborn. Additionally, Asda Pharmacy (Perth), Boots High Street and Boots Perth Road (Dundee). List of sexual and reproductive health clinics: Chalmers Sexual and Reproductive Health Service, NHS Lothian (Edinburgh), Tayside Sexual and Reproductive Health Service, Ninewells Hospital (Dundee), Camberwell Sexual Health Centre, Mortimer Market Centre, the Margaret Pyke Centre, and the Archway Centre (London). Declaration of interests: STC reports grants from the National Institute for Health Research (Health Technology Assessment [NIHR HTA] Programme), during the conduct of the study. AG is a consultant to HRA Pharma. AR reports receiving research grants from Gilead Sciences, Bristol-Myers Squibb, AbbVie, and Roche; honorariums from Gilead Sciences; and personal fees from AbbVie. LM and SP report funding from the UK Medical Research Council and Scottish Government Chief Scientist Office (Central Statistics Office) at the University of Glasgow (MC_UU_12017/11, SPHSU11). PB is a clinical director of the not-for profit community interest company SH:24, that provides online sexual health services in partnership with the UK National Health Service. KC reports being an employee of Boots UK, during the conduct of this study. AleM reports grants from NIHR HTA, during the conduct of this study. AleM is a clinical support bank midwife for SH:24 and a research midwife at Oxford University. JN was a deputy chair of the NIHR HTA General Board Committee (2016–19). All other authors declare no competing interests. This research is funded by the NIHR HTA project 15/113/01.en
dc.format.extent10
dc.format.extent452934
dc.language.isoeng
dc.relation.ispartofThe Lanceten
dc.subjectSDG 3 - Good Health and Well-beingen
dc.subjectRA0421 Public health. Hygiene. Preventive Medicineen
dc.subjectR Medicineen
dc.subjectGeneral Medicineen
dc.subjectMedical Research Council (MRC)en
dc.subjectMC_UU_12017/11en
dc.subjectChief Scientist Office (CSO)en
dc.subjectSPHSU11en
dc.subjectNational Institute for Health Research (NIHR)en
dc.subject15/113/01en
dc.subject.lccRA0421en
dc.subject.lccRen
dc.titleUse of effective contraception following provision of the progestogen-only pill for women presenting to community pharmacies for emergency contraception (Bridge-It) : a pragmatic cluster-randomised crossover trialen
dc.typeJournal articleen
dc.contributor.institutionUniversity of Aberdeen.Health Services Research Uniten
dc.contributor.institutionUniversity of Aberdeen.Institute of Applied Health Sciencesen
dc.description.statusPeer revieweden
dc.identifier.doi10.1016/S0140-6736(20)31785-2
dc.identifier.urlhttp://www.scopus.com/inward/record.url?scp=85096153496&partnerID=8YFLogxKen


Files in this item

Thumbnail
Name:
Cameron_et_al_TheLancet_UseOfE ...
Size:
442.3Kb
Format:
PDF
View/Open

This item appears in the following Collection(s)

Show simple item record